Chugai Pharmaceutical Co., Ltd. hereby announces that there is a difference regarding the individual financial results (Japanese standard) for the year ended December 2017 (Jan. 1, 2017 - Dec. 31, 2017) as compared to the actual results for the previous year (Jan. 1, 2016 - Dec. 31, 2016).

1.Difference between the actual results for the year ended December 2017 and the actual results for the previous year

Revenues Operating Income Ordinary Income Net Income Earnings per
Share
Actual results for the previous year (A)
（Year ended Dec. 2016） 		(millions of yen)
486,903 		(millions of yen)
69,048 		(millions of yen)
73,289 		(millions of yen)
50,907 		(Yen Sen)
93.21
Actual results for this year (B)
（Year ended Dec. 2017） 		(millions of yen)
526,052 		(millions of yen)
86,583 		(millions of yen)
91,772 		(millions of yen)
69,723 		(Yen Sen)
127.57
Change（B-A） (millions of yen)
39,149 		(millions of yen)
17,535 		(millions of yen)
18,483 		(millions of yen)
18,816 		-
Change（%） 8.0 25.4 25.2 37.0 -

2. Reasons for the difference occurring
The difference occurred mainly due to the strong performance of mainstay products, improvement in cost of sales from changes in product mix, and increase in royalties and other operating income.

Contact:
For Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group, Corporate Communications Dept.,
Koki Harada
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp

For Investors
Chugai Pharmaceutical Co., Ltd.
Investor Relations Group, Corporate Communications Dept.,
Toshiya Sasai
Tel: +81-3-3273-0554
E-mail: ir@chugai-pharm.co.jp

Chugai Pharmaceutical Co. Ltd. published this content on 01 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 February 2018 11:34:07 UTC.

Original documenthttp://www.chugai-pharm.co.jp/english/news/detail/20180201163000.html

Public permalinkhttp://www.publicnow.com/view/C98F8EE8A7EE489E9254CAB8E63039AA7F3B04E4